nCounter Gene Expression Grant Program for Dartmouth University

Helping your research with gene expression you can count on.

Calling all Dartmouth Researcher! Kick off your Summer with NanoString’s nCounter Gene Expression Research Grant Program.

The nCounter® platform provides a simple and cost-effective solution for multiplex analysis of up to 800 RNA, DNA, or protein targets. Accelerate your biomarker discovery and development with confidence and peace of mind. With robust performance on even the most difficult sample types and unparalleled flexibility in content and throughput, you can rapidly translate basic science discoveries into actionable clinical insights with the nCounter® Analysis System.

Apply today for a chance to win your choice of gene expression panel, including nCounter Elements TagSets & PlexSet Reagents! Check out the Panel Selection Tool to find what fits best for you.

One grant recipient will be awarded:

  • 24 samples of the panel they choose
  • 1:1 Project Consultation
  • Data Analysis Walkthrough
  • Appropriate Master Kit or Cartridge to run their project

Submit your project below! Application deadline: Monday, June 19

Terms and Conditions

Publication of Project Results:
All submissions are confidential to the individual submitter and will not be published or distributed; however, NanoString may share them with partners, collaborators and other third parties who are obligated to keep them confidential.

Eligibility and Requirements:
Applicants must be actively enrolled or employed at an institution or company in a capacity in which they perform life science research as a postdoctoral research fellow, research fellow, etc. Recipients must be age 18 or older. Members of the immediate families of NanoString employees and directors, and/or persons living in the same household as such persons, are ineligible to participate in this travel award grant program. The grant award allows for the recipient to run 12 samples worth of an nCounter 360 panel (choosing from the PanCancer IO 360, Breast Cancer 360, and Tumor Signaling 360 Panels) or neuroscience gene expression panel (choosing from the Neuropathology, Neuroinflammation, Glial Profiling, and Alzheimer’s Disease Panels) along with samples of Master Kits or Sprint Cartridges, whichever is applicable. Projects can be run at the University of Dartmouth.

By submitting an application, each applicant agrees that NanoString may use his or her name, abstract title, and abstract for marketing purposes. All applicants agree that NanoString may process the personal data he or she provides as part of the application, including sharing such data with NanoString’s partners, collaborators and other third parties who are obligated to keep the data confidential, and in accordance with NanoString’s privacy policies available at Award recipients may be required to sign and return an affidavit of eligibility, release of liability, a publicity release, and other appropriate legal documentation reasonably requested by NanoString. No substitution or transfer of the awarded stipend is allowed, except as otherwise permitted by NanoString. Grant winners are responsible for any local tax liability (city, state, or federal) occurred by winning and accepting the award. If, for any reason, this grant program may not run as planned for any causes beyond the reasonable control of NanoString, then NanoString reserves the right in its sole discretion to cancel, terminate, modify or suspend the grant program. NanoString has not made any warranty, representation, or guarantee, express or implied, with respect to the grant award and related services, including, without limitation, their quality or fitness for a particular purpose. This program is void where prohibited or otherwise restricted by law. These terms and conditions and any action related to this grant award program will be governed by the laws of the State of Washington without regard to or application of its conflict of law provisions or your state or country of residence. All claims, legal proceedings or litigation arising in connection with these terms and conditions and this grant program will be brought solely in the federal or state courts located in Seattle, Washington, and all applicants consent to the jurisdiction of and venue in such courts and waive any objection as to inconvenient forum. By participating in this grant program, each applicant unconditionally accepts and agrees to comply with and abide by these terms and conditions.